Intel is hoping for a turnaround under its new CEO, Lip-BuTan. Intel’s Q1 2025 revenue was $12.7 billion, flat year-over-year. While its Client Computing Group (CCG) revenue dropped 8%, the Data ...
Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback